期刊文献+

胸腔积液中hTERT mRNACEA CA19-9检测及其意义 被引量:9

Detection of hTERT mRNA, CEA, and CA199 in Pleural Fluid and Its Significance
下载PDF
导出
摘要 目的:探讨人端粒酶逆转录酶(human telomerase reverse transcriptase,hTERT)、CEA、CA19-9在鉴别诊断良恶性胸腔积液的意义。方法:采用全自动化学发光法检测胸腔积液中CEA、CA19-9含量及RT-PCR检测胸腔积液中hTERT mRNA表达。结果:恶性组中hTERTmRNA、CEA、CA19-9阳性率显著高于良性组(P<0.05)。三者在恶性胸腔积液的敏感性(%)、特异性(%)和诊断符合率(%)分别为:hTERT mRNA:81.8/90.5/86.1,CEA:52.3/92.9/72.1,CA19-9:34.1/90.5/61.6。hTERT mRNA+CEA在恶性胸腔积液中诊断阳性率97.7%。结论:三者均有助于良恶性胸腔积液的鉴别诊断,而hTERT mRNA对于鉴别良恶性胸腔积液有更大的临床价值,CA19-9不宜作为首选指标;hTERT mRNA和CEA联合检测可以进一步提高恶性胸腔积液的阳性检出率,有助于提高其诊断价值。 Objective: To.detect hTERT mRNA, CEA, and CA19-9 in pleural fluids and to explore their significance in the differential diagnosis of malignant and-benign effusions. Methods: The concentrations of CEA and CA19-9 in pleural fluids were measured by automated chemiluminescence and the expression of hTERT mRNA was detected by RT-PCR. Results: The positive rates of hTERT mRNA, CEA and CA19-9 were significantly higher in the malignant group than in the henigh group (P〈0.05). The sensitivity, specificity and diagnostic accordance Late. (%) of the three tumor markers were as follows: hTERT mRNA: 81.8%, 90.5%, and 86.1%; CEA: 52.3%, 92.9%, and 72.1%; CA19-9: 34.1%, 90.5%, and 61.6%. The positive rate of hTERT mRNA combined with CEA was 97.7%. Conclusion: Detection of hTERT mRNA, CEA, and CA19-9 can be helpful for the differential diagnosis of pleural effusions. The combined detection of hTERT mRNA and CEA in pleural effusions is a more helpful method.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第2期92-95,共4页 Chinese Journal of Clinical Oncology
基金 江西省卫生厅科研基金项目资助(编号:2004383)
关键词 胸腔积液hTERT MRNA CEA CA19-9 Pleural effusions hTERT mRNA CEA CA19-9
  • 相关文献

参考文献12

二级参考文献29

  • 1方修平.多指标联合检测对恶性胸腔积液的诊断价值[J].肿瘤研究与临床,2001,13(3):190-191. 被引量:10
  • 2[1]Kim NW, Piatyszek MA, Prowse KR, et al. Specific associa tion of human telomerase activity with immortal cells and cancer. Science, 1994, 266(5193): 2011~2015 被引量:1
  • 3[2]Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer, 1997, 33(5):781~786 被引量:1
  • 4[3]Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997, 33(5): 787~791 被引量:1
  • 5[4]Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagno sis by detection of exfoliated cancer cells in urine. Cancer, 1997, 79(2):362~369 被引量:1
  • 6[5]Yoshida K, Sugino T, Goodison S, et al. Detection of telom erase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer, 1997, 75(4):548~553 被引量:1
  • 7[6]Kyo S, Takakura M, Ishilcowa H, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res, 1997, 57(10): 1863~1867 被引量:1
  • 8[7]Mu XC, Brien TP, Ross JS, et al. Telomerase activity in be nign and malignant cytologic fluids. Cancer, 1999,87(2):93~99 被引量:1
  • 9[8]Toshima S, Arai T, Yasuda Y, et al. Cytological diagnostic and telomerase activity of cells in effusions of body cavities. Oncol Rep, 1999, 6(1):199~203 被引量:1
  • 10[9]Yang CT, Lee MH, Lan RS, et al. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol, 1998,16 (2):567~573 被引量:1

共引文献351

同被引文献55

引证文献9

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部